Anti-VEGF, anti-vascular endothelial growth factor; BCVA, best-corrected visual acuity; CFT, central foveal thickness; DR, diabetic retinopathy; ERP, epiretinal proliferation; ETDRS, Early Treatment Diabetic Retinopathy Study; HbA1c, glycated haemoglobin; IVF, intravitreal faricimab; SD, standard deviation. This evidence concerns the gene VEGFA and diabetic retinopathy.